NO20052817L - Anvendelse av EDG2-reseptor i en dyremodell for hjertesvikt - Google Patents
Anvendelse av EDG2-reseptor i en dyremodell for hjertesviktInfo
- Publication number
- NO20052817L NO20052817L NO20052817A NO20052817A NO20052817L NO 20052817 L NO20052817 L NO 20052817L NO 20052817 A NO20052817 A NO 20052817A NO 20052817 A NO20052817 A NO 20052817A NO 20052817 L NO20052817 L NO 20052817L
- Authority
- NO
- Norway
- Prior art keywords
- heart failure
- animal model
- edg2 receptor
- edg2
- receptor
- Prior art date
Links
- 206010019280 Heart failures Diseases 0.000 title 1
- 102000004137 Lysophosphatidic Acid Receptors Human genes 0.000 title 1
- 108090000642 Lysophosphatidic Acid Receptors Proteins 0.000 title 1
- 238000010171 animal model Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0271—Chimeric vertebrates, e.g. comprising exogenous cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/107—Rabbit
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/035—Animal model for multifactorial diseases
- A01K2267/0375—Animal model for cardiovascular diseases
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2517/00—Cells related to new breeds of animals
- C12N2517/02—Cells from transgenic animals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10341—Use of virus, viral particle or viral elements as a vector
- C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Toxicology (AREA)
- Environmental Sciences (AREA)
- Immunology (AREA)
- Virology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Animal Husbandry (AREA)
- Biodiversity & Conservation Biology (AREA)
- Veterinary Medicine (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02025161A EP1418185A1 (en) | 2002-11-11 | 2002-11-11 | Use of EDG2 receptor in an animal model of heart failure |
| PCT/EP2003/012325 WO2004044003A2 (en) | 2002-11-11 | 2003-11-05 | Use of edg2 receptor in an animal model of heart failure |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20052817D0 NO20052817D0 (no) | 2005-06-10 |
| NO20052817L true NO20052817L (no) | 2005-08-02 |
Family
ID=32103925
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20052817A NO20052817L (no) | 2002-11-11 | 2005-06-10 | Anvendelse av EDG2-reseptor i en dyremodell for hjertesvikt |
Country Status (10)
| Country | Link |
|---|---|
| EP (2) | EP1418185A1 (no) |
| JP (1) | JP4764006B2 (no) |
| KR (1) | KR20050086524A (no) |
| CN (1) | CN1711281A (no) |
| AU (1) | AU2003285314A1 (no) |
| CA (1) | CA2505197A1 (no) |
| NO (1) | NO20052817L (no) |
| RU (1) | RU2337963C2 (no) |
| WO (1) | WO2004044003A2 (no) |
| ZA (1) | ZA200502784B (no) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050003548A1 (en) * | 2002-07-22 | 2005-01-06 | Nikolay Korokhov | Targeted adenoviral vector displaying immunoglobulin-binding domain and uses thereof |
| JP2006262813A (ja) * | 2005-03-25 | 2006-10-05 | Kyushu Institute Of Technology | 受容体発現細胞とそれを用いた標的物質の機能の評価方法 |
| AU2010303737B2 (en) | 2009-10-06 | 2014-05-29 | Institute For Research In Biomedicine (Irb) | Genetically modified mice and engraftment |
| EP2476755A1 (en) * | 2011-01-17 | 2012-07-18 | Helmholtz-Zentrum für Infektionsforschung GmbH | S/MAR containing expression vectors, cell and cell lines as well as methods using the same |
| PT2675271T (pt) * | 2011-02-15 | 2018-10-11 | Univ Yale | Ratinhos humanizados para m-csf |
| RU2768282C2 (ru) | 2012-09-07 | 2022-03-23 | Йель Юниверсити | Генетически модифицированные не принадлежащие к человеческому роду животные и способ их использования |
| DK3939423T3 (da) | 2012-11-05 | 2024-05-06 | Regeneron Pharma | Genetisk modificerede ikke-humane dyr og fremgangsmåder til anvendelse deraf |
| RU2711744C1 (ru) | 2014-05-19 | 2020-01-21 | Ридженерон Фармасьютикалз, Инк. | Генетически модифицированные животные, отличные от человека, экспрессирующие epo человека |
| WO2015191508A1 (en) | 2014-06-09 | 2015-12-17 | Voyager Therapeutics, Inc. | Chimeric capsids |
| RU2716991C2 (ru) | 2014-11-05 | 2020-03-17 | Вояджер Терапьютикс, Инк. | Полинуклеотиды aadc для лечения болезни паркинсона |
| CA2977354C (en) | 2014-11-14 | 2021-09-21 | Regenesis Science Co., Ltd. | Method for serum-free culture of chondrocytes and serum-free culture medium |
| IL292999A (en) | 2014-11-14 | 2022-07-01 | Voyager Therapeutics Inc | Preparations and methods for the treatment of amyotrophic lateral sclerosis |
| JP6863891B2 (ja) | 2014-11-14 | 2021-04-21 | ボイジャー セラピューティクス インコーポレイテッドＶｏｙａｇｅｒ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． | 調節性ポリヌクレオチド |
| WO2016094783A1 (en) | 2014-12-12 | 2016-06-16 | Voyager Therapeutics, Inc. | Compositions and methods for the production of scaav |
| RU2020124128A (ru) | 2015-04-13 | 2020-09-22 | Ридженерон Фармасьютикалз, Инк. | Гуманизированные мыши с нокином sirpa-il15 и способы их использования |
| CA3006569A1 (en) | 2015-12-02 | 2017-06-08 | Voyager Therapeutics, Inc. | Assays for the detection of aav neutralizing antibodies |
| US11326182B2 (en) | 2016-04-29 | 2022-05-10 | Voyager Therapeutics, Inc. | Compositions for the treatment of disease |
| US11299751B2 (en) | 2016-04-29 | 2022-04-12 | Voyager Therapeutics, Inc. | Compositions for the treatment of disease |
| IL302748A (en) | 2016-05-18 | 2023-07-01 | Voyager Therapeutics Inc | modulatory polynucleotides |
| BR112018073472A2 (pt) | 2016-05-18 | 2019-08-27 | Voyager Therapeutics Inc | composições e métodos de tratamento da doença de huntington |
| CA3035522A1 (en) | 2016-08-30 | 2018-03-08 | The Regents Of The University Of California | Methods for biomedical targeting and delivery and devices and systems for practicing the same |
| CN111108198A (zh) | 2017-05-05 | 2020-05-05 | 沃雅戈治疗公司 | 治疗亨廷顿病的组合物和方法 |
| AU2018261790A1 (en) | 2017-05-05 | 2019-11-28 | Voyager Therapeutics, Inc. | Compositions and methods of treating amyotrophic lateral sclerosis (ALS) |
| JOP20190269A1 (ar) | 2017-06-15 | 2019-11-20 | Voyager Therapeutics Inc | بولي نوكليوتيدات aadc لعلاج مرض باركنسون |
| US11497576B2 (en) | 2017-07-17 | 2022-11-15 | Voyager Therapeutics, Inc. | Trajectory array guide system |
| JP7221275B2 (ja) | 2017-08-03 | 2023-02-13 | ボイジャー セラピューティクス インコーポレイテッド | Ａａｖを送達するための組成物および方法 |
| US20200237799A1 (en) | 2017-10-16 | 2020-07-30 | Voyager Therapeutics, Inc. | Treatment of amyotrophic lateral sclerosis (als) |
| WO2019079240A1 (en) | 2017-10-16 | 2019-04-25 | Voyager Therapeutics, Inc. | TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999019513A2 (en) * | 1997-10-10 | 1999-04-22 | Lxr Biotechnology, Inc. | Methods for detecting compounds which modulate the activity of an lpa receptor |
| CA2340334A1 (en) * | 1998-08-19 | 2000-03-02 | Millenium Pharmaceuticals, Inc. | 14274 receptor, a g-protein coupled receptor related to the edg receptor family |
-
2002
- 2002-11-11 EP EP02025161A patent/EP1418185A1/en not_active Withdrawn
-
2003
- 2003-11-05 CA CA002505197A patent/CA2505197A1/en not_active Withdrawn
- 2003-11-05 CN CNA2003801029702A patent/CN1711281A/zh active Pending
- 2003-11-05 AU AU2003285314A patent/AU2003285314A1/en not_active Abandoned
- 2003-11-05 EP EP03778300A patent/EP1562987A2/en not_active Withdrawn
- 2003-11-05 WO PCT/EP2003/012325 patent/WO2004044003A2/en active Application Filing
- 2003-11-05 JP JP2004550932A patent/JP4764006B2/ja not_active Expired - Fee Related
- 2003-11-05 RU RU2005118095/13A patent/RU2337963C2/ru not_active IP Right Cessation
- 2003-11-05 KR KR1020057008410A patent/KR20050086524A/ko not_active Application Discontinuation
-
2005
- 2005-04-06 ZA ZA200502784A patent/ZA200502784B/en unknown
- 2005-06-10 NO NO20052817A patent/NO20052817L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1418185A1 (en) | 2004-05-12 |
| NO20052817D0 (no) | 2005-06-10 |
| WO2004044003A2 (en) | 2004-05-27 |
| EP1562987A2 (en) | 2005-08-17 |
| CA2505197A1 (en) | 2004-05-27 |
| WO2004044003A3 (en) | 2004-06-17 |
| JP2006518187A (ja) | 2006-08-10 |
| ZA200502784B (en) | 2008-01-30 |
| RU2337963C2 (ru) | 2008-11-10 |
| CN1711281A (zh) | 2005-12-21 |
| KR20050086524A (ko) | 2005-08-30 |
| JP4764006B2 (ja) | 2011-08-31 |
| RU2005118095A (ru) | 2006-01-20 |
| AU2003285314A1 (en) | 2004-06-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20052817L (no) | Anvendelse av EDG2-reseptor i en dyremodell for hjertesvikt | |
| NO2017051I1 (no) | Kariprazin, eventuelt i form av et salt, inkludert kariprazin hydroklorid | |
| DE50311710D1 (de) | Absorptionskörper zum anschluss an den menschlichen körper | |
| FR16C1012I2 (fr) | Utilisation therapeutique d'anticorps anti-cs1 | |
| AU2003258534A1 (en) | Use of s1p receptor agonists in heart diseases | |
| DK1583763T3 (da) | Benzoazolylpiperazinderivater med VR1-antagonistaktivitet | |
| DK2298237T3 (da) | Hjerteprotese | |
| DE60301989D1 (de) | Medizinisches Ultraschallsystem | |
| NO20050426L (no) | Arylkarbonylderivater som terapeutiske midler | |
| NO20034465D0 (no) | Medisinsk pasientsimulator | |
| NO20044402L (no) | Kombinasjonsbehandling av kemokine-medierte sykdommer | |
| ATE395342T1 (de) | 2-carbamid-4-phenylthiazol-derivate, deren herstellung und therapeutische verwendung | |
| ATE361279T1 (de) | N-[phenyl(piperidin-2-yl)methyl]benzamidderivat , verfahren zu ihrer herstellung und ihre therapeutische anwendung | |
| DE602005023127D1 (de) | Künstliche physiologische salzlösung und verfahren zu ihrer herstellung | |
| IS7571A (is) | Ný lífeðlisfræðilega virk efni | |
| ATE459608T1 (de) | Oxopiperidinderivate, ihre herstellung und therapeutische verwendung | |
| DE602005026964D1 (de) | 2-amido-4-phenylthiazol-derivate, ihre herstellung und ihre therapeutische verwendung | |
| ATE417846T1 (de) | Aminotropanderivate, deren herstellung und deren therapeutische verwendung | |
| SE0301837L (sv) | Batterienhet | |
| DE60336775D1 (de) | Verteiltes Herzschrittsystem | |
| DE60318635D1 (de) | Herzstimulationsvorrichtung | |
| FI20021617A (fi) | Diagnostisia ja terapeuttisia menetelmiä | |
| FI20040930A (fi) | Menetelmä ja pulssimittari | |
| ES1051167Y (es) | Sofa perfeccionado | |
| UA7129S (uk) | Кіоск моделі «акцент-115» |